Leipzig, Germany – March 6th 2025 Adragos Pharma, a leading contract development and manufacturing organisation (CDMO), today announced the completion of a €4 million project to install and commission an advanced, cGMP-compliant liquid filling line and accompanying cartoning machine at […]
Munich / Courroux, November 25, 2024 – Adragos Pharma, a global pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Munich, Germany, has acquired Baccinex, a Swiss-based expert in aseptic fill-finish manufacturing. This acquisition significantly enhances Adragos’ sterile manufacturing capabilities […]
We are thrilled to announce the launch of our cutting-edge ampoule filling line at Adragos’ Livron facility in France, marking a transformative milestone in Project Future. This new line is a major investment in enhancing production capacity and furthering our […]
[Munich, October 22nd] – Adragos Pharma, a global Contract Development and Manufacturing Organization (CDMO), is proud to announce its participation in the Science Based Targets initiative (SBTi), marking a significant commitment to environmental sustainability and corporate responsibility in the fight […]
The Adragos Livron site is thrilled to announce two major milestones that are set to redefine our production capabilities and reinforce our commitment to excellence in pharmaceutical manufacturing. Project FUTURE: A New Chapter in Ampoule Production As part of our […]
Adragos Pharma is actively pursuing contract manufacturing in the Japanese market. Leveraging ex-Sanofi’s Kawagoe plant (located Kawagoe City, Saitama Prefecture) which they acquired one year ago as their flagship manufacturing site, they are reinvesting on solid dosage manufacturing to serve […]
Get notified on our latest news.
